Publications by Dr Paul Mackin - ePrints

Browsing publications by Dr Paul Mackin.

Newcastle Authors	Title	Year
Dr Peter Gallagher James Newham Professor Allan Young Emeritus Professor Nicol Ferrier Dr Paul Mackin et al.	Antiglucocorticoid treatments for mood disorders (Withdrawn Paper. 2015, Art. no. CD005168)	2015
Dr Paul Mackin Anthony Waton Helen Watkinson Dr Peter Gallagher	A four-year naturalistic prospective study of cardiometabolic disease in antipsychotic-treated patients.	2012
Dr Kirstie Anderson Anthony Waton Dr Daniel Armstrong Helen Watkinson Dr Paul Mackin et al.	Sleep disordered breathing in community psychiatric patients	2012
Dr Paul Mackin Professor Simon Thomas	Atypical antipsychotic drugs	2011
Dr Paul Mackin Dr Amit Nulkar Anthony Waton Helen Watkinson	Prolactin and smoking status in antipsychotic-treated patients	2011
Dr Dawn Clewes Helen Watkinson Dr Paul Mackin	Ambulatory Polysomnography to Investigate Obstructive Sleep Apneoa (OSA) in Secondary Care Community Psychiatry Service Patients	2010
Dr Niraj Ahuja Dr Paul Mackin Dr Adrian Lloyd	Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature	2010
Anthony Waton Dr Amit Nulkar Helen Watkinson Dr Paul Mackin	Prolactin, Smoking Status and Cardiovascular Risk in Community Psychiatric Patients	2010
Dr Stuart Watson Dr Paul Mackin	HPA axis function in mood disorders	2009
Dr Paul Mackin Helen Watkinson Emeritus Professor Nicol Ferrier	A prospective study of glycaemic status in anti-psychotic-treated patients	2008
Dr Peter Gallagher Dr James Newham Professor Allan Young Emeritus Professor Nicol Ferrier Dr Paul Mackin et al.	Antiglucocorticoid treatments for mood disorders	2008
Emeritus Professor Nicol Ferrier Dr Paul Mackin	Authors' reply	2008
Dr Paul Mackin	Cardiac side effects of psychiatric drugs	2008
Dr Paul Mackin	Cardiac side effects of psychiatric drugs	2008
Emeritus Professor Nicol Ferrier Dr Paul Mackin	Wake-up call for British psychiatry	2008
Dr Paul Mackin Helen Watkinson	A prospective study of metabolic disease and monitoring practices in antipsychotic-treated community psychiatric patients	2007
Dr Paul Mackin Helen Watkinson	A prospective study of metabolic disease and monitoring practices in antipsychotic-treated community psychiatric patients	2007
Dr Paul Mackin Helen Watkinson	A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients	2007
Dr Paul Mackin	Assessment of manic symptoms in different cultures - Author's reply	2007
Dr Paul Mackin	Author's reply [8]	2007
Dr Paul Mackin Dr Peter Gallagher	Authors' reply [9]	2007
Dr Paul Mackin Dr Peter Gallagher	Cardiovascular risk with antipsychotics: case-control study or survey? Reply	2007
Dr Paul Mackin Dr Peter Gallagher Dr Stuart Watson Professor Allan Young Emeritus Professor Nicol Ferrier et al.	Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia	2007
Dr Laura Hampson Dr Paul Mackin Professor Loranne Agius	Control of glycogen metabolism in hepatocytes by serotonergic mechanisms and counter-regulation of the glycogenic effect by second-generation antipsychotic drugs	2007
Dr Paul Mackin Helen Watkinson Dr Peter Gallagher Emeritus Professor Nicol Ferrier	Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community	2007
Dr Paul Mackin Dr Peter Gallagher Helen Watkinson Emeritus Professor Nicol Ferrier	Metabolic disease and cardiovascular risk in psychiatric out-patients taking antipsychotic drugs	2007
Dr Paul Mackin	Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia	2007
Dr Laura Hampson Dr Paul Mackin Professor Loranne Agius	Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs	2007
Dr Paul Mackin Dr Peter Gallagher Dr Stuart Watson Professor Allan Young Emeritus Professor Nicol Ferrier et al.	Antiglucocorticoid treatment in mood disorders: A Cochrane systematic review	2006
Dr Paul Mackin Professor Allan Young	Culture and assessment of manic symptoms	2006
Dr Paul Mackin Professor Allan Young	Drs. Mackin and Young reply	2006
Jill Thompson Dr John Gray Dr Paul Mackin Professor Allan Young Emeritus Professor Nicol Ferrier et al.	Executive and visuospatial sketchpad resources in euthymic bipolar disorder: Implications for visuospatial working memory architecture	2006
Dr Stuart Watson Dr Paul Mackin	HPA axis function in mood disorders	2006
Dr Paul Mackin Professor Allan Young	QTc and metabolic parameters - Drs. Mackin and Young reply	2006
Dr Paul Mackin Professor Hamish McAllister-Williams	Schizophrenia and increased risk of cardiovascular disease	2006
Dr Paul Mackin Dr Peter Gallagher Professor Allan Young	Antiglucocorticoid treatments in mood disorders: efficacy and safety (Protocol)	2005
Dr Paul Mackin	Brain-derived neurotrophic factor (BDNF), stress and affective disorders	2005
Dr Paul Mackin Professor Hamish McAllister-Williams	Fronto-temporal dementia: remembering images from the past	2005
Dr Paul Mackin Professor Allan Young	Hypothalamic-pituitary-adrenal axis and bipolar disorder	2005
Dr Paul Mackin Helen Watkinson Professor Allan Young	Metabolic disease in patients taking typical and atypical antipsychotic drugs	2005
Dr Paul Mackin	Monitoring of metabolic disease in secondary and tertiary care in psychiatric outpatients taking antipsychotic drugs	2005
Dr Paul Mackin Dr Stuart Watson Emeritus Professor Nicol Ferrier	Neurobiology of depression : focus on brain-derived neurotrophic factor, cortisol and their interactions	2005
Dr Paul Mackin Helen Watkinson Professor Allan Young	Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: A cross-sectional study	2005
Dr Paul Mackin Professor Allan Young	Prognosis in obesity: Obesity in severe mental illness poses particular problems	2005
Dr Paul Mackin Professor Allan Young	QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: A preliminary study	2005
Dr Paul Mackin	Rapid cycling is equivalently prevalent in bipolar I and bipolar II disorder, and is associated with female gender and greater severity of illness	2005
Dr Paul Mackin Dr Peter Gallagher	Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes (multiple letters)	2005
Dr Paul Mackin Dr Peter Gallagher Professor Dame Louise Robinson	Stilettos and Schizophrenia	2005
Dr Paul Mackin Professor Allan Young	The HPA axis in bipolar disorder	2005
Dr Paul Mackin Professor Allan Young	To: Mackin P, Watkinson HM, Young AH (2005) Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: A cross-sectional study. Diabetologia 48:215-221	2005
Dr Paul Mackin	Weight gain and antipsychotics	2005
Dr Paul Mackin	Weight gain and antipsychotics [3] (multiple letters)	2005
Dr Paul Mackin Professor Allan Young	Bipolar Disorders in Core Psychiatry	2004
Dr Paul Mackin Professor Allan Young	Diagnosis and treatment of bipolar depression	2004
Dr Peter Gallagher Dr Stuart Watson Dr Paul Mackin Emeritus Professor Nicol Ferrier Professor Allan Young et al.	Efficacy of mifepristone (RU-486) in schizophrenia	2004
Dr Peter Gallagher Dr Paul Mackin Emeritus Professor Nicol Ferrier Professor Allan Young	Mifepristone (RU-486) in the treatment of schizophrenia	2004
Margaret Smith Dr Peter Gallagher Dr Stuart Watson Dr Paul Mackin Emeritus Professor Nicol Ferrier et al.	Neurocognitive and neuroendocrine effects of mifepristone (RU-486) in schizophrenia	2004
Dr Paul Mackin Professor Allan Young	Rapid cycling bipolar disorder: Historical overview and focus on emerging treatments	2004
Dr Paul Mackin Professor Allan Young	Reply to Dr. J-C Shim and colleagues regarding "fluoxetine augmentation of haloperidol in chronic schizophrenia" [J Clin Psychopharmacol 2003;23:520-521] [1]	2004
Dr Paul Mackin	Reply to Fischer & Broderick. Sodium Valproate or valproate semisodium: is there a difference in the treatment of bipolar disorder?	2004
Dr Paul Mackin Professor Allan Young	Reply to Shim, et al. regarding Fluoxetine augmentation of haloperidol in chronic schizophrenia	2004
Jill Thompson Dr John Gray Dr Paul Mackin Emeritus Professor Nicol Ferrier Professor Allan Young et al.	The executive-visuo-spatial sketchpad interface in euthymic bipolar disorder: implications for visuo-spatial working memory architecture	2004
Dr Paul Mackin Professor Allan Young	The role of cortisol and depression: exploring new opportunities for treatments	2004
Dr Paul Mackin Professor Allan Young	What's new in psychiatry	2004
Dr Chankramath Arun Jan Stoddart Dr Paul Mackin Emerita Professor Sally Marshall	Significance of microalbuminuria in long-duration type 1 diabetes	2003
Dr Paul Mackin Dr Stephen Ball Dr Sarah Johnson Professor Thomas Lennard George Proud et al.	Parathyroid carcinoma: clinical, biochemical and pathological features of three recent cases	1999